Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs56960757 | chr2:241537047 | C/T | 3.44E-5 | 178 | 25.92 | 20.2 | 10.3 | KM Plot |
PCPG | rs57023839 | chr16:1772892 | T/C | 2.51E-11 | 170 | 25.67 | 19.3 | 4.52 | KM Plot |
PCPG | rs57071566 | chr16:89889327 | T/G | 0.000198 | 172 | 26.22 | 20.28 | 36.37 | KM Plot |
PCPG | rs57137641 | chr12:56741228 | G/A | 9.68E-8 | 177 | 25.17 | 29.13 | 9.98 | KM Plot |
PCPG | rs57218552 | chr14:74370600 | G/C | 1.16E-5 | 176 | 25.4 | 27.2 | 10.43 | KM Plot |
PCPG | rs57255862 | chr2:236192482 | C/T | 3.73E-7 | 170 | 27.2 | 24.7 | 3.07 | KM Plot |
PCPG | rs57279772 | chr12:56698960 | G/A | 1.01E-7 | 177 | 25.35 | 29.13 | 0.8 | KM Plot |
PCPG | rs57298399 | chr7:158659884 | G/C | 0 | 175 | 25.53 | 20.37 | 3.17 | KM Plot |
PCPG | rs57317059 | chr2:24309082 | A/G | 0.00011 | 178 | 25.28 | 26.92 | 17.43 | KM Plot |
PCPG | rs57337179 | chr2:241539478 | C/T | 3.44E-5 | 178 | 25.92 | 20.2 | 10.3 | KM Plot |
PCPG | rs57343616 | chr12:56623347 | C/T | 1.37E-7 | 174 | 25.08 | 32.6 | 0.8 | KM Plot |
PCPG | rs57366408 | chr2:19020144 | T/A | 7.32E-5 | 172 | 24.85 | 32.15 | 17.42 | KM Plot |
PCPG | rs57367440 | chr12:56745788 | T/C | 9.85E-8 | 177 | 25.35 | 27.33 | 9.98 | KM Plot |
PCPG | rs57375947 | chr13:37564741 | C/CAT | 0.00031 | 176 | 4.17 | 24.47 | 25.87 | KM Plot |
PCPG | rs57383328 | chr17:80504952 | C/CA | 5.49E-5 | 172 | 26.57 | 19.72 | 7.2 | KM Plot |